# Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas

Source: https://onco.cc/trials/nct06872541/  
OnCo record `nct06872541` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2/3 trial in lung cancer, run by University of Sao Paulo, active but no longer recruiting.

## Summary

Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas is a phase 2/3, interventional study registered as NCT06872541 by University of Sao Paulo, with a registry enrolment figure of 100 participants, started 2025-01-20 and due to reach its primary completion in 2026-10-20. Interventions recorded: Clopidogrel. Conditions listed: Assessment of Platelet Aggregability in Patients Patients with Non-small Cell Lung Carcinoma. Primary outcome: Platelet Aggregation analyzed by optical aggregometry-ADP (AggRAM™- Helena Laboratories). Lung eligibility wording from the registry: "* Confirmed diagnosis of non-small cell lung carcinoma in the case group; absence of history of any neoplasia for control group". Sites: Brazil. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06872541
- Phase: 2/3
- Setting: Evaluation of Platelet Aggregability in Patients with Non-small Cell Lung Carcinomas
- Sponsor: University of Sao Paulo
- Enrolled: 100

## Sources

- ClinicalTrials.gov NCT06872541: https://clinicaltrials.gov/study/NCT06872541

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06872541.json